Skip to main content
. 2022 Jul 25;10(7):e4450. doi: 10.1097/GOX.0000000000004450

Table 2.

Characteristics of the Series: Operation

Variable Total (N = 47)
Size of implant (g), mean ± SD 348.66 ± 86.54
 (minimum–maximum) (90.00–515.00)
 Missing, n (%) 6 (12.8)
LPF total (g), mean ± SD 284.13 ± 62.94
 (minimum–maximum) (160.00–490.00)
Contralateral operation, n (%)
 No 33 (70.2)
 Prosthesis removal 7 (14.9)
 Mastopexy and breast reduction (<150 g) 3 (6.4)
 Breast reduction (≥150 g) 4 (8.5)
Operative time (min)
 General operative time, mean ± SD 108.93 ± 17.65
  (minimum–maximum) (74.00–146.00)
  Missing, n (%) 4 (8.5)
 No contralateral operation, mean ± SD 104.07 ± 16.42
  (minimum–maximum) (74.00–145.00)
  Missing, n (%) 3 (9.1)
 Contralateral operation prosthesis removal, mean ± SD 114.71 ± 12.93
  (minimum–maximum) (95.00–138.00)
 Contralateral operation mastopexy or breast reduction (<150 g), md (IQR) 111.50 (95.00–128.00)
  (minimum–maximum) (95.00–128.00)
  Missing, n (%) 1 (33.3)
 Contralateral operation breast reduction (≥150 g), mean ± SD 134.00 ± 8.98
  (minimum–maximum) (125.00–146.00)

%, relative frequency; IQR, interquartile range (percentiles 25th–75th); LPF, liposuctioned fat; md, median; n, absolute frequency; SD, standard deviation.